Send to

Choose Destination
J Am Coll Cardiol. 2019 Jul 23;74(3):362-372. doi: 10.1016/j.jacc.2019.06.012.

Coronary Artery Disease and Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.

Author information

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada. Electronic address:


About one-half of transcatheter aortic valve replacement (TAVR) candidates have coronary artery disease (CAD), and controversial results have been reported regarding the effect of the presence and severity of CAD on clinical outcomes post-TAVR. In addition to coronary angiography, promising data has been recently reported on both the use of computed tomography angiography and the functional invasive assessment of coronary lesions in the work-up pre-TAVR. While waiting for the results of ongoing randomized trials, percutaneous revascularization of significant coronary lesions has been the routine strategy in TAVR candidates with CAD. Also, scarce data exists on the incidence, characteristics, and management of coronary events post-TAVR, and increasing interest exist on potential coronary access challenges in patients requiring coronary angiography/intervention post-TAVR. This review provides an updated overview of the current landscape of CAD in TAVR recipients, focusing on its prevalence, clinical impact, pre- and post-procedural evaluation and management, unresolved issues and future perspectives.


TAVR; coronary artery disease; coronary computed tomography angiography; fractional flow reserve


Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center